Morgan Stanley to increase sale of loans tied to Musk's X, Bloomberg News reports
A group of Morgan Stanley-led banks is set to increase a sale of loans tied to Elon Musk's social media platform X after ...
Why Morgan Stanley's CIO says investors should expect weak stock returns for the next 3 months
The S&P 500 will trade in a range that implies the index dropping as much as 8% or rising a little over 1% in the coming ...
Morgan Stanley's legendary fund manager Dennis Lynch is off to a hot start in 2025 — and these 3 stocks helped drive his 10% return in January
Fresh off of his stellar year in 2024, Dennis Lynch is Business Insider's Investor of the Month for January.
AMD price target lowered to $147 from $158 at Morgan Stanley
Morgan Stanley analyst Joseph Moore lowered the firm’s price target on AMD (AMD) to $147 from $158 and keeps an Equal Weight ...
Morgan Stanley Names New Investment Bank Heads For Mideast
Morgan Stanley has appointed Pradyut Pratap and Usman Akram as joint heads of its investment bank in the Middle East and ...
Ball Corp. price target lowered to $70 from $75 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Ball Corp. (BALL) to $70 from $75 and keeps an Overweight rating on the shares. Ball shares ...
bovnews37m
Why Did Stanley Black & Decker Inc (SWK) Stock Plunge -2.45% Last Week?
Stanley Black & Decker Inc (SWK) stock saw a modest uptick, ending the day at $86.66 which represents a slight increase of $1.49 or 1.75% from the prior close of $85.17. The stock opened at $85.29 and ...
Morgan Stanley aumenta venta de deuda de X ante fuerte demanda
Un grupo de bancos liderado por Morgan Stanley aumentará sustancialmente la venta de préstamos vinculados a la plataforma de ...
Morgan Stanley's top stock strategist says the market is in a 'sweet spot' when it comes to interest rates
The Fed made the right call in hitting pause this week. "I'm not sure that pausing is really all the bad for stocks in the ...
Nurix Therapeutics (NASDAQ:NRIX) Stock Price Expected to Rise, Morgan Stanley Analyst Says
Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) had its price objective lifted by analysts at Morgan Stanley from $16.00 ...